Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

8. Marijuana, Hallucinogens, and Club Drugs 177ing bodies of evidence, however, and the possible public health implications,are a call for effective prevention and education interventions.REFERENCESAbel, E. L. (1980). Marijuana: The first twelve thousand years. New York: Plenum Press.Ajaelo, I., Koenig, K., & Snoey, E. (1998). Severe hyponatremia and inappropriateantidiuretic hormone secretion following ecstasy use. Acad Emerg Med, 5, 939–840.American Academy of Ophthalmology. (1992, June). The use of marijuana in the treatmentof glaucoma. Statement by the Board of Directors of the American Academyof Ophthalmology, San Francisco.Ames, D., & Wirshing, W. (1993). Ecstasy, the serotonin syndrome, and neurolepticmalignant syndrome—a possible link? JAMA, 269, 869–870.Arseneault, L. Cannon, M., Witton, J., & Murray, R. M. (2004). Causal associationbetween cannabis and psychosis: Examination of the evidence. Br J Psychiatry, 194,110–117.Beck, J. (1990). The public health implications of MDMA use. In S. J. Peroutka (Ed.),Ecstasy: The clinical, pharmacological and neurotoxicological effects of the drug MDMA(pp. 77–103). Boston: Kluwer Academic.Beck, J., & Rosenbaum, M. (1994). Pursuit of Ecstasy: The MDMA experience. Albany:State University of New York Press.Bellis, M. A., Hale, G., Bennett, A., Chaudry, M., & Kilfoyle, M. (2000). Ibiza uncovered:Changes in substance use and sexual behavior amongst young people visitingan international nightlife resort. Int J Drug Policy, 11, 235–244.Block, R. I. (1996). Does heavy marijuana use impair human cognition and brain function?JAMA, 275, 560–561.Bonnie, R. J., & Whitebread, C. H. (1974). The marijuana conviction: A history of marijuanaprohibition in the United States. Charlottesville: University of Virginia Press.Boys, A., Lenton, S., & Norcross, K. (1997). Polydrug use at raves by a Western Australiansample. Drug Alcohol Rev, 16, 227–234.Bubser, M., Keseberg, U., Notz, P. K., & Griffiths, P. (1992). Differential behavioraland neurochemical effects of competitive and noncompetitive NMDA receptorantagonists in rats. Eur J Pharmacol, 229, 75–82.Budney, A. J., Moore, B. A., Vandrey, R. G., & Hughes, J. R. (2003). The time courseand significance of cannabis withdrawal. J Abnorm Psychol, 112, 393–402.Buffum, J., & Moser, C. (1986). MDMA and human sexual function. J PsychoactiveDrugs, 18, 355–359.Burgess, C., O’Donoghoe, A., & Gill, M. (2000). Agony and ecstasy: A review ofMDMA effects and toxicity. Eur Psychiatry, 15, 287–294.CESAR, the Center for Substance Abuse Research. (2004). Inhalant abuse: Nothing tosniff at. CESAR Fax, 13(12).Chin, M. Y., Kreutzer, R. A., & Dyer, J. E. (1992). Acute poisoning from gammahydroxybutyratein California. West J Med, 156, 380–384.